Additional research supports an elevated OPG to the receptor activator of nuclear factor kappa B ligand (RANKL) ratio as a potential indicator of endothelial dysfunction progression in autoimmune disorders; the alteration of OPG to RANKL proportion is considered to have therapeutic implications [14]. Here, TNFRSF11B is linked to endothelial dysfunction.